PharmiWeb.com - Global Pharma News & Resources

PressReleases - 2019-08-05

Date Title Company
05-Aug-2019 LA BioMed Scientists Developing a Vaccine to Protect Against Deadly Superbug LA BioMed
05-Aug-2019 Santhera Announces Closing of Licensing Transaction with Chiesi Group for Raxone® in LHON Santhera
05-Aug-2019 Sermonix Pharmaceuticals Closes US$26 Million Series A Financing Round Led by WILD Family Office Sermonix Pharmaceuticals
05-Aug-2019 Almac Group Invites Biopharma Industry Members to Learn About Almac Adapt™ - Just in Time Manufacturing at Complimentary Workshop Almac Group
05-Aug-2019 VMS BioMarketing Announces Appointment of Brion Brandes as SVP of Business Development VMS BioMarketing
05-Aug-2019 Results of the Pivotal Phase 3 Study of the Bempedoic Acid / Ezetimibe Combination Tablet Published in the European Journal of Preventative Cardiology Demonstrated Significant LDL-C Lowering Daiichi Sankyo Europe GmbH
05-Aug-2019 Change in number of shares and votes in Moberg Pharma AB (publ) Moberg Pharma
05-Aug-2019 Approval of darolutamide is based on the Phase III ARAMIS trial evaluating the efficacy and safety of darolutamide plus androgen deprivation therapy (ADT) compared to placebo plus ADT. Darolutamide was approved under the FDA Priority Review designation. Orion Corporation
05-Aug-2019 Five years on, 3.9 million people in the developing world have access to HIV treatment dolutegravir, thanks to access-oriented voluntary licensing agreements ViiV Healthcare
05-Aug-2019 PredictImmune closes Series B funding round, raising £10M to further accelerate global commercial expansion and support expanding product pipeline PredictImmune
05-Aug-2019 European Medicines Agency Grants PRIME Access to ProQR’s Sepofarsen for Leber’s Congenital Amaurosis 10 European Medicines Agency
05-Aug-2019 MR Solutions receives a Third Queen’s Award for innovative PET imaging technology in pre-clinical scanners MR Solutions
05-Aug-2019 Sanofi provides update on ZynquistaTM (sotagliflozin) type 2 diabetes Phase 3 program and collaboration with Lexicon Sanofi
05-Aug-2019 Abeona Therapeutics Announces Positive Interim Data from the ABO-102 Phase 1/2 Gene Therapy Clinical Trial in MPS IIIA Abeona Therapeutics
05-Aug-2019 Bioz Expands Its Badge Program to Increase Life Science Product Marketing ROI Bioz
05-Aug-2019 Genmab Announces the Closing of Over-Allotment Option in Initial Public Offering of American Depositary Shares (ADSs) in the United States and Registration of Capital Increase Genmab
05-Aug-2019 CEL-SCI’s Scientific Review on Inflammatory Disease Therapies Published in Peer Reviewed Journal “International Immunopharmacology” CEL-SCI Corporation
05-Aug-2019 Novel Drug Being Developed for HIV Prevention and Cancer Indications Demonstrates Best-in-Class Potency Orion Biotechnology Canada
05-Aug-2019 The taboo subject of constipation: undermining patient’s quality of life and putting a preventable strain on NHS The Bowel Interest Group launches 2019 ‘Cost of Constipation’ report The Bowel Interest Group
05-Aug-2019 Hardy Diagnostics Releases New Room Temperature Storage Sterile Environmental Monitoring Plates Hardy Diagnostics